Interferon Signaling Is Frequently Downregulated in Melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interferon Signaling Is Frequently Downregulated in Melanoma

Published:2018-06-21 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Alavi Sara,Stewart Ashleigh Jacqueline,Kefford Richard F.,Lim Su Yin,Shklovskaya Elena,Rizos Helen

Funder

National Health and Medical Research Council

Center for Integrative Natural Science and Mathematics, Northern Kentucky University

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference35 articles.

1. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab;Topalian;J Clin Oncol,2014

2. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma;Larkin;N Engl J Med,2015

3. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015

4. Association of pembrolizumab with tumor response and survival among patients with advanced melanoma;Ribas;JAMA,2016

5. Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade;Benci;Cell,2016

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A chronic signaling TGFb zebrafish reporter identifies immune response in melanoma;eLife;2024-06-14

2. The role of PD-1/PD-L1 signaling pathway in cancer pathogenesis and treatment: a systematic review;Journal of Cancer Metastasis and Treatment;2024-05-28

3. Tryptophanyl-Transfer RNA Synthetase Is Involved in a Negative Feedback Loop Mitigating Interferon-γ-Induced Gene Expression;Cells;2024-01-17

4. Identifying biomarkers associated with immunotherapy response in melanoma by multi-omics analysis;Computers in Biology and Medicine;2023-12

5. The Prognostic and Predictive Value of Human Gastrointestinal Microbiome and Exosomal mRNA Expression of PD-L1 and IFNγ for Immune Checkpoint Inhibitors Response in Metastatic Melanoma Patients: PROTOCOL TRIAL;Biomedicines;2023-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3